Sweetgreen: Turnaround Is Slipping, Valuation Hasn't Reset Enough
Sweetgreen reported Q2 2026 earnings after the bell on Thursday, and the stock dropped 16.8% the next day. It's another 7% lower on Friday morning, trading around $5.45. Over the past 20 days, the stock is down 34.8%. Year-to-date, it is down 19%. The 52-week high was $10.63 — the stock has halved from there.
The quarter didn't reverse the trajectory. Same-store sales fell 6.2% year-over-year. That is an improvement from the 7.6% decline in the same quarter a year ago, but a decline is still a decline, and the company now guides full-year comps to fall 7% to 8%. Restaurant-level profit margin collapsed to 13.1%, down from 18.9% a year ago, dragged lower by weaker traffic, aggressive promotional activity, and higher ingredient costs from portion investments in chicken and tofu.
My view: Hold. The valuation is cheap by the multiples, but the business is deteriorating faster than the stock, and there's no clear catalyst that justifies buying into a food safety outbreak, collapsing margins, and compounding comp-store declines. The market still hasn't finished pricing the downside.
Quick Backtesting Tool
What changed in the quarter
Revenue came in at $192.7 million, up 3.8% year-over-year but missing the consensus estimate of $193.9 million. The topline growth was entirely from 36 net new stores opened since last year — $18.4 million in incremental revenue. The existing restaurant base lost $11.2 million.
That decomposition matters. It means SweetgreenSG-- is growing only by building new locations while its core business shrinks. For a restaurant chain with 285 stores and a brand that's supposed to scale, that's a structural problem, not a quarter-off blip.
GAAP EPS was a $0.22 loss, 44% worse than the consensus $0.15 loss estimate. Adjusted EBITDA came to nearly zero at -$200,000, missing the $5.67 million estimate by a wide margin. Net loss widened to $26.3 million, a 13.6% margin.
The company gave no reconciliation of its forward non-GAAP guidance to GAAP, citing uncertainty. When a company won't reconcile its own projections, it means the downside is large enough that management prefers you not see the full picture.
The margin collapse tells the real story
Restaurant-level profit margin — the profit generated at the store before corporate overhead — fell from 18.9% to 13.1%, a 600-basis-point drop. That is the single most important metric in this report because it shows the unit economics are cracking under three pressures at once:
- Traffic is down 2.0%, meaning fewer customers are walking through the door.
- Product mix shifted down 4.2%, driven by a menu shift toward lower-margin wraps and the removal of ripple fries (which had been a higher-margin add-on).
- Promotional activity increased, eating into average check size.
Meanwhile, ingredient costs rose as the company invested in larger chicken and tofu portions — an attempt to improve perceived value that is destroying the margin without bringing back the customers it's trying to win over.
On the corporate side, G&A expense came down to $29.7 million from $34.5 million a year ago. That's a real improvement — $2.8 million from lower stock-based compensation and $1.2 million from reduced management salaries. Cost-cutting is working at the head office. It just isn't working at the registers.
The cyclospora problem
Management's updated full-year guidance explicitly calls out a multi-state cyclosporiasis outbreak starting mid-July as the reason for the downgrade. Cyclospora is a parasitic illness linked to contaminated produce. A nine-state investigation has been underway since July, though Sweetgreen itself has not been linked to confirmed cases. The company issued a voluntary recall of some jalapeños on Wednesday.
That distinction — not being the source but being collateral damage — is what makes this so hard to price. The FDA investigation hasn't pointed to Sweetgreen, but the company says diners are eating less fresh prepared food as a result, and that's baked into the new -7% to -8% comp-store guidance. The outbreak adds a demand headwind on top of an existing structural decline.
The cash burn
The balance sheet is the metric that should keep risk-tolerant buyers on the sidelines. Free cash flow over the trailing twelve months is -$123.7 million, down 50% year-over-year. The company burned $10.6 million in free cash flow in Q2 alone. Operating cash flow for the year is -$27.6 million.
Capex is $96 million TTM — the company is still building stores (about 13 more planned this year, half with Infinite Kitchen automation technology) while the existing base is bleeding. The company has $156.8 million in cash and $423.8 million in total debt. That means net debt is roughly zero, but the cash runway is tight if free cash flow stays in the range of -$120 million annually.
At this burn rate, the company has maybe a year of cash on hand before it needs to refinance, dilute, or cut capex aggressively. That's not an immediate bankruptcy risk — but it is a hard constraint on how long management can afford to wait for the turnaround to show results.
Valuation: cheap, but not cheap enough
The stock trades at 0.73x EV/sales on an enterprise value of $491 million against $681 million in trailing revenue. Market cap is $648 million. Price-to-book is 1.3x. By the multiples, this is a beaten-down small-cap restaurant stock.
But cheap multiples don't work in isolation. At 0.73x EV/sales, the market is pricing Sweetgreen as a business that will continue to shrink its comp-store base, burn cash, and struggle to find a path to profitability. That's not a punishment multiple — that's a realistic one for a restaurant chain with declining traffic, collapsing store-level margins, and a product category under consumer pressure from a food safety outbreak.
For comparison, Chipotle trades at 3.35x sales and generates positive free cash flow with double-digit comp growth and a 29x P/E. The gap isn't just about growth. It's about whether the unit economics still work.
The valuation would become compelling — the kind of multiple compression that creates a buy-the-dip opportunity — if one of three things happened: (a) comp-store sales flatten or turn positive, (b) restaurant-level margins stabilize above 15%, or (c) free cash flow stops burning at a rate that threatens the balance sheet within 12 months. None of those things are visible right now.
The turnaround plan has no clock
CEO Jonathan Neman said results were "not where they need to be" while expressing confidence in the "Sweet Growth Transformation Plan." The company is rolling out Infinite Kitchen automation, pushing wraps, growing digital (66.3% of revenue, up from 60.8%), and increasing owned digital through its loyalty program (38.8%, up from 33.4%).
Those are real initiatives. But they're also initiatives that have been in the works for quarters without changing the comp-store trajectory. Digital penetration rising doesn't help if total transactions are falling. Owned digital growing doesn't matter if the average check is declining. And automation technology is a cost reduction story that only works if traffic comes back.
The consensus EPS estimates for the next two quarters are -$0.17 (Q3) and -$0.31 (Q4). The losses are getting bigger, not smaller. The forward P/E is negative. There is no quarter on the horizon where the market can see a profit inflection.
What would change my view
I would upgrade to a Buy if:
- Comp-store sales print flat or positive for two consecutive quarters, signaling the traffic decline has stabilized.
- Restaurant-level profit margin recovers to above 15%, showing that the portion and promotional experiments are finding a sustainable balance.
- Free cash flow for a quarter comes in positive or near-zero, proving the capex spend on new stores isn't outpacing store-level economics.
- The cyclospora outbreak investigation closes without further impact on the fresh-prepared-food category.
If the stock falls another 20% or more on additional bad news, the valuation would cross into territory where the risk/reward starts to tilt — around $4.50 or below, which would push EV/sales toward 0.6x and compress the market cap to under $500 million. At that point, the question becomes whether the company can survive long enough to execute on the turnaround, and the balance sheet would be the deciding factor.
Rating: Hold
Sweetgreen is not out of the woods. The comp-store decline is structural, the margin collapse is real, the cash burn is unsustainable, and a food safety outbreak is adding demand headwinds on top of the existing problems. The valuation is cheap by the multiples, but the business is deteriorating faster than the stock, and there's no near-term catalyst that justifies buying before the market finishes its work.
Wait for proof that comps stabilize, margins recover, and the cash burn slows. The current setup has too much risk for the valuation discount to compensate.
